GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC (LGND) | 8/7/2026 4:16:58 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $63,693,000 +33.7% | Assets $2,185,875,000 | EPS $2.22 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/6/2026 7:06:45 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $63,693,000 +33.7% | Assets $2,185,875,000 | EPS $2.22 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2026 4:25:00 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $51,722,000 +14.1% | Assets $1,532,105,000 | EPS -$0.67 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/7/2026 7:16:45 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $51,722,000 +14.1% | Assets $1,532,105,000 | EPS -$0.67 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/21/2026 4:06:07 PM | View | Proxy | SEC | Y 2025 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/27/2026 4:12:57 PM | Mid | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $268,087,000 +60.4% | Assets $1,560,637,000 | EPS $6.13 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/26/2026 7:08:18 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $59,666,000 +39.4% | Assets $1,560,637,000 | EPS $2.18 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/7/2025 4:15:43 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $115,461,000 +122.8% | Assets $1,476,772,000 | EPS $5.68 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/6/2025 7:08:49 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $115,461,000 +122.8% | Assets $1,476,772,000 | EPS $5.68 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2025 4:22:15 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $47,627,000 +14.7% | Assets $948,604,000 | EPS $0.24 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/7/2025 7:06:03 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $47,627,000 +14.7% | Assets $948,604,000 | EPS $0.24 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/10/2025 4:02:03 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $45,333,000 +46.3% | Assets $905,435,000 | EPS -$2.21 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2025 7:07:34 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $45,333,000 +46.3% | Assets $905,435,000 | EPS -$2.21 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/22/2025 4:09:11 PM | View | Proxy | SEC | Y 2024 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/28/2025 4:14:41 PM | Mid | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $167,133,000 +27.3% | Assets $941,774,000 | EPS -$0.22 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/27/2025 7:07:15 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $42,812,000 +52.4% | Assets $941,774,000 | EPS -$1.68 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2024 4:14:18 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $51,812,000 +57.6% | Assets $954,866,000 | EPS -$0.39 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/7/2024 7:13:38 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $51,812,000 +57.6% | Assets $954,866,000 | EPS -$0.39 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/7/2024 4:46:08 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $41,531,000 +57.5% | Assets $866,405,000 | EPS -$2.88 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/6/2024 4:09:37 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $41,531,000 +57.5% | Assets $866,405,000 | EPS -$2.88 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2024 4:20:29 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $30,978,000 -29.6% | Assets $913,869,000 | EPS $4.75 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/7/2024 4:06:10 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $30,978,000 -29.6% | Assets $913,869,000 | EPS $4.75 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/25/2024 6:05:07 AM | View | Proxy | SEC | Y 2023 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/29/2024 4:52:07 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $131,314,000 -33.1% | Assets $787,216,000 | EPS $2.94 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/27/2024 7:24:49 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $28,101,000 -44.2% | Assets $787,216,000 | EPS $1.03 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/13/2023 6:03:23 AM | View | Correction | SEC | 3Q 2023 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2023 5:18:02 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $32,868,000 -44.5% | Assets $769,226,000 | EPS -$0.59 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2023 4:10:26 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $32,868,000 -44.5% | Assets $769,226,000 | EPS -$0.59 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/9/2023 4:17:42 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $26,366,000 -47.4% | Assets $758,105,000 | EPS $0.13 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2023 4:04:11 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $26,366,000 -47.4% | Assets $758,105,000 | EPS $0.13 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2023 4:21:28 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $43,979,000 +20.4% | Assets $811,076,000 | EPS $2.33 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/4/2023 4:12:35 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $43,979,000 +20.4% | Assets $811,076,000 | EPS $2.33 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/20/2023 4:09:18 PM | View | Proxy | SEC | Y 2022 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/28/2023 4:18:52 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $196,245,000 -18.8% | Assets $762,668,000 | EPS -$1.98 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/22/2023 4:07:49 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $50,382,000 -10.7% | Assets $762,668,000 | EPS -$1.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2022 4:15:43 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $59,221,000 -0.8% | Assets $1,050,605,000 | EPS $0.02 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/7/2022 4:05:51 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $59,221,000 -0.8% | Assets $1,050,605,000 | EPS $0.02 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/11/2022 4:04:26 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $50,126,000 -36.4% | Assets $1,076,288,000 | EPS -$0.05 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2022 4:07:26 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $50,126,000 -36.4% | Assets $1,076,288,000 | EPS -$0.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2022 4:27:47 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $36,516,000 -21.6% | Assets $1,105,184,000 | EPS -$0.91 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/4/2022 4:08:47 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $36,516,000 -21.6% | Assets $1,105,184,000 | EPS -$0.91 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/22/2022 4:13:27 PM | View | Proxy | SEC | Y 2021 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/28/2022 6:34:30 PM | Mid | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $241,544,000 +47.7% | Assets $1,297,590,000 | EPS $3.31 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/17/2022 4:05:27 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $56,404,000 -19.4% | Assets $1,297,590,000 | EPS -$0.33 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2021 5:20:53 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $59,694,000 +42.6% | Assets $1,273,656,000 | EPS $0.80 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2021 4:11:08 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $59,694,000 +42.6% | Assets $1,273,656,000 | EPS $0.80 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/3/2021 6:11:41 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $78,854,000 +90.4% | Assets $1,256,283,000 | EPS $1.79 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 7/29/2021 4:07:11 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $78,854,000 +90.4% | Assets $1,256,283,000 | EPS $1.79 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/6/2021 4:25:29 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $46,592,000 +40.5% | Assets $1,295,121,000 | EPS $1.05 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/3/2021 4:12:51 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $46,592,000 +40.5% | Assets $1,295,121,000 | EPS $1.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/23/2021 4:12:01 PM | View | Proxy | SEC | Y 2020 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/24/2021 5:44:07 PM | Mid | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $163,562,000 +36.0% | Assets $1,362,285,000 | EPS -$0.18 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/3/2021 7:46:05 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $69,990,000 +159.2% | Assets $1,362,285,000 | EPS $0.35 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/12/2020 4:25:25 PM | View | Proxy | SEC | Y 2019 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 11/6/2020 4:24:07 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $41,848,000 +68.7% | Assets $1,247,449,000 | EPS -$0.42 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 10/30/2020 8:04:16 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $41,848,000 +68.7% | Assets $1,247,449,000 | EPS -$0.42 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 10/20/2020 10:54:49 AM | View | Presentation | SEC | Y 2020 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 8/7/2020 5:33:01 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $41,420,000 +65.8% | Assets $1,242,936,000 | EPS $1.32 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/3/2020 7:49:51 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $41,420,000 +65.8% | Assets $1,242,936,000 | EPS $1.32 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2020 4:36:01 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $33,161,000 -23.7% | Assets $1,185,917,000 | EPS -$1.46 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/6/2020 4:09:28 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $33,161,000 -23.7% | Assets $1,185,917,000 | EPS -$1.46 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/24/2020 4:06:50 PM | View | Proxy | SEC | Y 2019 | ||||||
| Ligand Pharmaceuticals Inc (LGND) | 4/22/2020 8:32:58 AM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $33,161,000 -23.7% | Assets $1,185,917,000 | EPS -$1.46 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/6/2020 5:15:55 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2020 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/27/2020 5:43:15 PM | Mid | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $120,282,000 -52.2% | Assets $1,494,915,000 | EPS $31.85 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/6/2020 4:08:10 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $27,003,000 -54.7% | Assets $1,494,915,000 | EPS -$0.43 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2019 4:43:51 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $24,808,000 -45.7% | Assets $1,547,476,000 | EPS -$0.81 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/5/2019 4:09:47 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $24,808,000 -45.7% | Assets $1,547,476,000 | EPS -$0.81 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2019 4:26:58 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $24,987,000 -72.2% | Assets $1,801,836,000 | EPS -$0.74 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 7/30/2019 8:14:11 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $24,987,000 -72.2% | Assets $1,801,836,000 | EPS -$0.74 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2019 4:24:59 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $43,484,000 -22.6% | Assets $1,913,988,000 | EPS $31.32 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/2/2019 4:16:55 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $43,484,000 -22.6% | Assets $1,913,988,000 | EPS $31.32 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/24/2019 6:03:12 AM | View | Proxy | SEC | Y 2018 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/28/2019 5:02:16 PM | Mid | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $251,453,000 +78.2% | Assets $1,260,803,000 | EPS $5.96 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/7/2019 4:21:26 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $59,590,000 0.0% | Assets $1,260,803,000 | EPS -$2.02 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2018 4:14:48 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $45,663,000 +36.8% | Assets $2,105,742,000 | EPS $2.80 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2018 8:15:01 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $45,663,000 +36.8% | Assets $2,105,742,000 | EPS $2.80 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2018 5:26:53 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $90,043,000 +221.6% | Assets $1,858,284,000 | EPS $2.99 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/6/2018 5:02:30 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $90,043,000 +221.6% | Assets $1,858,284,000 | EPS $2.99 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2018 5:30:30 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $56,157,000 +91.9% | Assets $754,668,000 | EPS $1.83 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2018 4:13:49 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $56,157,000 +91.9% | Assets $754,668,000 | EPS $1.83 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/30/2018 4:18:58 PM | View | Proxy | SEC | Y 2017 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 3/1/2018 5:22:39 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $141,102,000 +29.5% | Assets $671,021,000 | EPS $0.53 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/21/2018 4:09:42 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $59,590,000 +56.1% | Assets $671,021,000 | EPS -$2.02 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2017 4:22:08 PM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $33,375,000 +54.4% | Assets $662,337,000 | EPS $2.80 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2017 4:05:14 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $33,375,000 +54.4% | Assets $662,337,000 | EPS $2.80 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/9/2017 6:07:21 AM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $27,995,000 +43.4% | Assets $640,024,000 | EPS $2.99 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2017 5:35:02 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $29,267,000 -1.3% | Assets $629,723,000 | EPS $1.83 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2017 4:05:05 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $29,267,000 -1.3% | Assets $629,723,000 | EPS $1.83 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/14/2017 9:24:22 AM | View | Proxy | SEC | Y 2016 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/28/2017 7:37:26 AM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $108,973,000 +51.5% | Assets $601,585,000 | EPS -$0.08 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/23/2017 4:06:12 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $38,186,000 +80.2% | Assets $601,585,000 | EPS $0.15 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/15/2016 5:30:00 AM | Small | View | Financials | 10-Q/A | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $19,521,000 +6.0% | Assets $589,318,000 | EPS -$0.30 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/15/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $21,619,000 +22.1% | Assets $600,865,000 | EPS $0.05 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/15/2016 5:30:00 AM | Small | View | Financials | 10-Q/A | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $29,648,000 +103.0% | Assets $585,957,000 | EPS $0.30 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/15/2016 5:30:00 AM | Small | View | Financials | 10-K/A | SEC | Y 2015 ending: 12/31/2015 | Rev: $71,914,000 +11.4% | Assets $503,061,000 | EPS $10.83 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/14/2016 5:34:05 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $21,619,000 +22.1% | Assets $600,865,000 | EPS $0.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/3/2016 4:04:22 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $21,619,000 +22.1% | Assets $600,865,000 | EPS $0.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/4/2016 4:22:05 PM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $19,521,000 +6.0% | Assets $589,318,000 | EPS -$0.30 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/4/2016 9:06:58 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $19,521,000 +6.0% | Assets $589,318,000 | EPS -$0.30 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/9/2016 8:30:36 AM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $29,648,000 +103.0% | Assets $585,957,000 | EPS $0.30 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/4/2016 6:07:16 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $29,648,000 +103.0% | Assets $585,957,000 | EPS $0.30 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/12/2016 4:03:27 PM | View | Proxy | SEC | Y 2015 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/26/2016 4:02:59 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $71,914,000 +11.4% | Assets $503,061,000 | EPS $10.83 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/10/2016 4:04:50 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $21,193,000 -7.9% | Assets $503,061,000 | EPS $0.29 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2015 5:26:11 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $17,701,000 +18.2% | Assets $496,326,000 | EPS $9.28 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2015 4:04:27 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $17,701,000 +18.2% | Assets $496,326,000 | EPS $9.28 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/5/2015 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $18,418,000 +73.6% | Assets $304,762,000 | EPS $1.11 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/4/2015 4:06:02 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $18,418,000 +73.6% | Assets $304,762,000 | EPS $1.11 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/11/2015 8:38:24 AM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $14,602,000 -8.5% | Assets $263,223,000 | EPS $0.04 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/11/2015 8:34:00 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $14,602,000 -8.5% | Assets $263,223,000 | EPS $0.04 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 3/12/2015 5:51:12 PM | View | Proxy | SEC | Y 2014 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/23/2015 4:28:52 PM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $64,538,000 +31.8% | Assets $258,029,000 | EPS $0.56 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/9/2015 8:37:45 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $22,999,000 +56.1% | Assets $258,029,000 | EPS $0.34 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 12/12/2014 4:02:17 PM | Micro | View | Financials | 10-K/A | SEC | Y 2013 ending: 12/31/2013 | Rev: $48,973,000 +56.0% | Assets $104,713,000 | EPS $0.55 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 12/1/2014 5:09:56 PM | Micro | View | Financials | 10-K/A | SEC | Y 2013 ending: 12/31/2013 | Rev: $48,973,000 +56.0% | Assets $104,713,000 | EPS $0.55 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 10/31/2014 4:23:44 PM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $14,973,000 +15.1% | Assets $272,283,000 | EPS $0.06 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 10/27/2014 8:05:13 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $14,973,000 +15.1% | Assets $272,283,000 | EPS $0.06 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/5/2014 5:22:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $10,608,000 +10.7% | Assets $99,847,000 | EPS $0.07 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/4/2014 8:33:03 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $10,608,000 +10.7% | Assets $99,847,000 | EPS $0.07 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 7/17/2014 8:06:13 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $10,608,000 +10.7% | Assets $99,847,000 | EPS $0.07 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/7/2014 5:30:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $15,958,000 +37.0% | Assets $105,471,000 | EPS $0.10 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/7/2014 8:34:06 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $15,958,000 +37.0% | Assets $105,471,000 | EPS $0.10 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/21/2014 5:08:41 PM | View | Proxy | SEC | Y 2013 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/24/2014 2:52:31 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $48,973,000 +56.0% | Assets $104,713,000 | EPS $0.55 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/11/2014 8:36:20 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $14,737,000 +8.1% | Assets $104,713,000 | EPS $0.09 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2013 5:28:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $13,005,000 +104.0% | Assets $101,677,000 | EPS $0.09 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 10/30/2013 8:52:24 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $13,005,000 +104.0% | Assets $101,677,000 | EPS $0.09 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/1/2013 10:23:35 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $9,580,000 +66.8% | Assets $99,571,000 | EPS $0.30 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/1/2013 8:33:00 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $9,580,000 +66.8% | Assets $99,571,000 | EPS $0.30 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2013 4:09:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $11,651,000 +106.7% | Assets $98,363,000 | EPS $0.07 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/8/2013 4:04:48 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $11,651,000 +106.7% | Assets $98,363,000 | EPS $0.07 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/25/2013 5:56:46 PM | View | Proxy | SEC | Y 2012 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 3/14/2013 7:07:46 AM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $31,388,000 +4.5% | Assets $104,260,000 | EPS -$0.03 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/13/2013 4:06:14 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $13,635,000 +5.4% | Assets $104,260,000 | EPS $0.05 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/14/2012 2:05:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $6,375,000 +11.0% | Assets $97,506,000 | EPS -$0.01 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/14/2012 2:03:28 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $5,742,000 -23.1% | Assets $102,827,000 | EPS -$0.13 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/14/2012 2:01:44 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $5,636,000 +44.7% | Assets $110,031,000 | EPS $0.06 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/14/2012 1:59:37 PM | Micro | View | Financials | 10-K/A | SEC | Y 2011 ending: 12/31/2011 | Rev: $30,037,000 +27.6% | Assets $120,583,000 | EPS $0.49 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/5/2012 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $6,375,000 +11.0% | Assets $97,506,000 | EPS -$0.01 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2012 5:21:13 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $5,742,000 -23.1% | Assets $102,827,000 | EPS -$0.13 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $5,742,000 -23.1% | Assets $102,827,000 | EPS -$0.13 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/4/2012 6:23:08 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $5,636,000 +44.7% | Assets $110,031,000 | EPS $0.06 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/2/2012 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $5,636,000 +44.7% | Assets $110,031,000 | EPS $0.06 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 4/27/2012 4:57:37 PM | View | Proxy | SEC | Y 2011 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/23/2012 5:28:03 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $30,037,000 +27.6% | Assets $120,583,000 | EPS $0.49 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/10/2012 5:02:51 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $5,741,000 -26.4% | Assets $123,158,000 | EPS -$0.21 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/10/2012 5:01:00 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $7,463,000 +27.8% | Assets $127,977,000 | EPS -$0.02 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 2/7/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $12,937,000 +228.4% | Assets $120,583,000 | EPS $0.23 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2011 4:30:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $5,741,000 -26.4% | Assets $123,158,000 | EPS -$0.21 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/8/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $5,741,000 -26.4% | Assets $123,158,000 | EPS -$0.21 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2011 4:14:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $7,463,000 +27.8% | Assets $127,977,000 | EPS -$0.02 | |
| LIGAND PHARMACEUTICALS INC (LGND) | 8/8/2011 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $7,463,000 +27.8% | Assets $127,977,000 | EPS -$0.02 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 5/10/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $3,896,000 | EPS $0.49 | Export Earnings Model | ||
| LIGAND PHARMACEUTICALS INC (LGND) | 4/29/2011 4:04:07 PM | View | Proxy | SEC | Y 2010 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/15/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $3,940,000 | Assets $75,559,000 | EPS $0.23 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 1/26/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $3,940,000 | Assets $75,559,000 | EPS $0.23 | Export Earnings Model | |
| LIGAND PHARMACEUTICALS INC (LGND) | 11/9/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $7,802,000 | EPS -$0.60 | Export Earnings Model | ||
| LIGAND PHARMACEUTICALS INC (LGND) | 8/12/2010 11:56:05 AM | View | Proxy | SEC | Y 2009 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 8/5/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $5,838,000 | EPS -$0.01 | Export Earnings Model | ||
| LIGAND PHARMACEUTICALS INC (LGND) | 5/5/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 4/23/2010 5:23:20 PM | View | Proxy | SEC | Y 2009 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/9/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 11/5/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 8/3/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 5/11/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 5/6/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| LIGAND PHARMACEUTICALS INC (LGND) | 4/29/2009 5:29:20 PM | View | Proxy | SEC | Y 2008 | ||||||
| LIGAND PHARMACEUTICALS INC (LGND) | 2/13/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |